E-LIB Suche - Ergebnisse für: Kahl, Lesley

1

Pharmacokinetic and pharmacokinetic/pharmacodynamic charact..:

Mehta, Rashmi ; Lagishetty, Chakradhar V. ; Angelis, Konstantinos...
British Journal of Clinical Pharmacology. 89 (2023) 7 - p. 2190-2200 , 2023

Link: https://doi.org/10.1111/..

2

A phase I, first‐in‐human study investigating the safety, t..:

Benn, Paul D. ; Zhang, Ying ; Kahl, Lesley...
Pharmacology Research & Perspectives. 11 (2023) 3 - p. , 2023

Link: https://doi.org/10.1002/..

3

2484. Patient Reported Outcomes After Switching to a 2-Drug..:

Oglesby, Alan ; Angelis, Kostas ; Punekar, Yogesh...
Open Forum Infectious Diseases. 6 (2019) Supplement_2 - p. S861-S861 , 2019

Link: https://doi.org/10.1093/..

4

319. SWORD 1 and 2: Switch from TDF Containing Regimen to D..:

Kahl, Lesley ; McComsey, Grace A ; Coronado Poggio, Monica...
Open Forum Infectious Diseases. 6 (2019) Supplement_2 - p. S169-S170 , 2019

Link: https://doi.org/10.1093/..

5

Sword 1 and 2: Subgroup Analysis of 48 Week Results by Age,..:

Walmsley, Sharon ; Richmond, Gary ; Bredeek, Fritz...
Open Forum Infectious Diseases. 4 (2017) suppl_1 - p. S427-S427 , 2017

Link: https://doi.org/10.1093/..

6

Salmeterol HFA is as effective as salmeterol CFC in childre..:

Chopra, Narinder ; Williams, Michael ; Rimmer, Martin..
Respiratory Medicine. 99 (2005) - p. S1-S10 , 2005

Link: https://doi.org/10.1016/..

7

A phase II safety and efficacy study of amprenavir in combi..:

Haubrich, Richard ; Thompson, Melanie ; Schooley, Robert...
AIDS. 13 (1999) 17 - p. 2411-2420 , 1999

Link: https://doi.org/10.1097/..

8

Biochemical characterization of the protective membrane gly..:

Rivas, Luis ; Kahl, Lesley ; Manson, Kelledy.
Molecular and Biochemical Parasitology. 47 (1991) 2 - p. 235-243 , 1991

Link: https://doi.org/10.1016/..

9

Brief Report: Evaluation of Inflammation and Atherogenesis ..:

Llibre, Josep M. ; López Cortés, Luis Fernando ; Aylott, Alicia...
JAIDS Journal of Acquired Immune Deficiency Syndromes. 91 (2022) 1 - p. 73-78 , 2022

Link: https://doi.org/10.1097/..

10

Brief Report: Durable Suppression and Low Rate of Virologic..:

van Wyk, Jean ; Orkin, Chloe ; Rubio, Rafael...
JAIDS Journal of Acquired Immune Deficiency Syndromes. 85 (2020) 3 - p. 325-330 , 2020

Link: https://doi.org/10.1097/..

11

Babesia bovis: Proteins of virulent and avirulent parasites..:

Kahl, Lesley P. ; Mitchell, G.F. ; Dalgliesh, Robert J....
Experimental Parasitology. 56 (1983) 2 - p. 222-235 , 1983

Link: https://doi.org/10.1016/..

12

A phase I, first‐in‐human study investigating the safety, t..:

Benn, Paul D ; Zhang, Ying ; Kahl, Lesley...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238757/. , 2023

Link: http://www.ncbi.nlm.nih...

13

2484. Patient Reported Outcomes After Switching to a 2-Drug..:

Oglesby, Alan ; Angelis, Kostas ; Punekar, Yogesh...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809953/. , 2019

Link: http://www.ncbi.nlm.nih...

14

319. SWORD 1 and 2: Switch from TDF Containing Regimen to D..:

Kahl, Lesley ; McComsey, Grace A ; Coronado Poggio, Monica...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809771/. , 2019

Link: http://www.ncbi.nlm.nih...

15

Sword 1 and 2: Subgroup Analysis of 48 Week Results by Age,..:

Walmsley, Sharon ; Richmond, Gary ; Bredeek, Fritz...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631252/. , 2017

Link: http://www.ncbi.nlm.nih...